Life Sciences Investment Banking
An experienced team in a vibrant sector.
Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.
Life Sciences Subsector Expertise
- Biotechnology
- Pharmaceutical Services
- Pharmaceutical Technology
- Pharmaceutical Supply Chain
- Specialty Pharmaceuticals
Senior Banking Team
















Transaction History
Transaction history may include a transaction completed by a Raymond James & Associates banker while at a former firm.
Recent News
Investment Banking
|
March 31, 2025
Raymond James hires John E. Mack III as co-head of security & safety investment banking sector team
Read more about Raymond James hires John E. Mack III as co-head of security & safety investment banking sector team
Investment Banking
|
March 11, 2025
Raymond James hires two senior IT services investment bankers
Read more about Raymond James hires two senior IT services investment bankers
Investment Banking
|
March 5, 2025